Medtronic's Q2 Results Weren't Splashy but Beat Expectations
Medtronic (NYSE: MDT) is underperforming the S&P 500 index so far in 2019, but most investors won't complain about a 22% year-to-date gain. The medical device giant delivered solid, if not spectacular, fiscal 2020 first-quarter results in August. Investors were hoping for more good news with Medtronic's Q2 results.
Those hopes were realized when the company provided its Q2 update on Tuesday morning. Here are the highlights from Medtronics' latest quarterly results.
Image source: Getty Images.
Source Fool.com